+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immunosuppressive Drugs Market Research Reports

From
Immunomodulators - Global Strategic Business Report - Product Thumbnail Image

Immunomodulators - Global Strategic Business Report

  • Report
  • May 2024
  • 94 Pages
  • Global
From
From
From
Graft Versus Host Disease (GvHD) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Graft Versus Host Disease (GvHD) - Epidemiology Forecast - 2032

  • Report
  • August 2023
  • 102 Pages
  • Global
From
Post-Transplant Lymphoproliferative Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Post-Transplant Lymphoproliferative Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Antibody-Mediated Graft Rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Antibody-Mediated Graft Rejection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Chronic Renal/Kidney Transplant Rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Renal/Kidney Transplant Rejection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Kidney Transplant Rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Kidney Transplant Rejection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Ocular Graft versus host Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Ocular Graft versus host Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Acute Graft-versus-Host Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Graft-versus-Host Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Lung transplant rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Lung transplant rejection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Graft versus host disease - Pipeline Insight, 2024 - Product Thumbnail Image

Graft versus host disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 220 Pages
  • Global
From
Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • February 2024
  • 60 Pages
  • Global
From
Glucocorticoid induced tumor necrosis factor - Pipeline Insight, 2024 - Product Thumbnail Image

Glucocorticoid induced tumor necrosis factor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Interleukin-2 (IL-2) Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-2 (IL-2) Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Glucocorticoid receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Glucocorticoid receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Immunosuppressive Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that suppress the immune system. These drugs are used to treat autoimmune diseases, organ transplant rejection, and other conditions where the immune system is overactive. Immunosuppressive drugs work by blocking the action of certain cells in the immune system, preventing them from attacking healthy tissue. Immunosuppressive drugs are typically administered orally or intravenously, and can be used in combination with other treatments such as steroids or chemotherapy. Common side effects of immunosuppressive drugs include nausea, vomiting, diarrhea, and increased risk of infection. Some of the major companies in the Immunosuppressive Drugs market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more